Milestone Scientific Announces Chicago Dental Society's 143rd Midwinter Meeting Proved Successful
March 06 2008 - 8:45AM
PR Newswire (US)
LIVINGSTON, N.J., March 6 /PRNewswire-FirstCall/ -- Milestone
Scientific Inc. (OTC:MLSS) (BULLETIN BOARD: MLSS) , the recognized
leader in advanced injection technologies, today announced that
during the month of February, dentists purchased more units of the
STA(TM) System, a patented, computer-controlled local anesthetic
delivery (CCLAD) system for dental injections, than in any month
since its introduction in 2007. Bob Presutti, Vice President of
Sales and Marketing at Milestone, stated, "It is evident that the
value proposition of the STA System has begun to resonate with
dental professionals nationwide. We believe this is largely due to
key refinements and more effective communication of our marketing
messages which took effect shortly before the year end holidays,
coupled with the growing number of highly satisfied STA users who
are enthusiastically sharing their positive opinions of the STA
System with their dental industry peers." In response to
surprisingly weak STA sales following its debut early last year,
this past Fall Milestone initiated an in-depth review and analysis
of the STA System's product positioning and messaging platform,
providing for comprehensive surveying of dental practitioners and
industry thought leaders. "The data compiled from our research
clearly reflected that we needed to do a much better job of
clarifying to the dental community that the STA System can be used
for all injections, not simply the periodontal intraligamentary
injection (single tooth anesthesia)," noted Presutti. "Our
surveying confirmed that when giving injections to patients, many,
if not most, dentists experience a similar level of fear, stress
and discomfort as the patient undergoing the actual treatment.
However, according to Marty Jablow, DMD, a dental practitioner in
Woodbridge, New Jersey, 'The STA System allows me to begin every
injection technique with significantly less stress for me and the
patient.' As a consequence of these findings, we have applied what
we learned and have begun to see meaningful and positive progress
indicated in our overall market penetration efforts." At the recent
Chicago Dental Society's 143rd Midwinter Meeting, held in Chicago,
held in late February, both Milestone and Henry Schein, Inc., the
Company's distributor in the U.S. and Canada, showcased the STA
System as a premier product in their respective booths. Traffic
through both companies' exhibit areas remained constant and robust
and resulted in a significant number of STA Systems being sold to
attendees over this important three day event. In February,
dentists purchased more units of the STA System than in any other
month since the product launch. The Midwinter Meeting is among the
top three dental meetings in the U.S. and one of the top 10
conventions in Chicago. Each year, more than 600 exhibiting
companies participate in the meeting, creating one of the largest
exhibits of dental products and manufacturers in North America.
About Milestone Scientific Inc. Headquartered in Livingston, New
Jersey, Milestone Scientific is engaged in pioneering proprietary,
highly innovative technological solutions for the medical and
dental markets. Central to the Company's IP platform and product
development strategy is its patented CompuFlo(TM) technology for
the improved and painless delivery of local anesthetic.
Specifically, CompuFlo is a computer-controlled, pressure sensitive
infusion, perfusion, suffusion and aspiration technology, which
provides real-time readouts of pressures, fluid densities and flow
rates, enabling the advanced delivery and removal of a wide array
of fluids. The Single Tooth Anesthesia (STA(TM))
computer-controlled local anesthesia delivery system which uses
this technology provides dentists with audible and visual signals
as to in-tissue pressure. Milestone's existing painless injection
systems are currently sold in 25 countries. For more information on
these and other innovative Milestone products, please visit the
Company's web site found at http://www.milesci.com/. Safe Harbor
Statement This press release contains forward-looking statements
regarding the timing and financial impact of the Milestone's
ability to implement its business plan, expected revenues and
future success. These statements involve a number of risks and
uncertainties and are based on assumptions involving judgments with
respect to future economic, competitive and market conditions and
future business decisions, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
on Form 10-KSB for the year ended December 31, 2006. The forward
looking-statements in this press release are based upon
management's reasonable belief as of the date hereof. Milestone
undertakes no obligation to revise or update publicly any
forward-looking statements for any reason. FOR MORE INFORMATION,
PLEASE CONTACT: Elite Financial Communications Group, LLC Dodi
Handy, President and CEO, or Daniel Conway, Chief Strategy Officer
407-585-1080 or via email at DATASOURCE: Milestone Scientific Inc.
CONTACT: Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategy Officer, both of Elite Financial Communications Group,
LLC, +1-407-585-1080, , for Milestone Scientific Inc. Web site:
http://www.milesci.com/
Copyright